REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aptus Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Aptus Pharma Private Limited Profile Updated: February 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Aptus Pharma Private Limited is an unlisted company, incorporated on 12/08/2010. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2010PTC061957 and registration number is 061957. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Near Dharam Cinema
Rajkot; Gujarat; Postal Code: 360001

Contact Details: Purchase the Aptus Pharma Private Limited report to view the information.

Website: http://www.aptus-pharma.com

Basic Information
Total Employees:
Purchase the Aptus Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Aptus Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Aptus Pharma Private Limited report to view the information.
Incorporation Date:
August 12, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Aptus Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.27%▲
Total operating revenue
32.27%▲
Operating profit (EBIT)
127.73%▲
EBITDA
112.62%▲
Net Profit (Loss) for the Period
140.83%▲
Total assets
55.27%▲
Total equity
28.5%▲
Operating Profit Margin (ROS)
1.01%▲
Net Profit Margin
0.79%▲
Return on Equity (ROE)
10.34%▲
Debt to Equity Ratio
54.35%▲
Quick Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo